Mary Ann Liebert, Inc: See What’s New from Human Gene Therapy and GEN

Mary Ann Liebert Inc. is the proud publisher of groundbreaking, peer-reviewed journals including Human Gene Therapy and The CRISPR Journal, providing all-inclusive coverage of the research, developments, and novel technologies that are driving today's explosion of gene therapy advances. Its flagship trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and remains the key driver in the growth of the industry, paving the way for the development of new technologies and applications, and  investment and career opportunities.